Unsaturated fatty alcohol derivatives of olive oil phenolic compounds with potential low-density lipoprotein (LDL) antioxidant and antiobesity properties

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 4, 2012, Pages 1067-1074

  Cotrim, Bruno Almeida ^a,b,e   Joglar, Jesús ^c   Rojas, M Jesús L ^a,d   Del Olmo, Juan Manuel Decara ^d   MacIas González, Manuel ^e,f   Cuevas, Miguel Romero ^d   Fitó, Montserrat ^a,e   Muñoz Aguayo, Daniel ^a   Covas Planells, María Isabel ^a,e   Farré, Magí ^a,g   Rodríguez De Fonseca, Fernando ^d,e   De La Torre, Rafael ^a,b,e  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^e Instituto de Salud Carlos III   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

CB ; ether; fatty alcohol; obesity; PPAR

Indexed keywords

ANTIOXIDANT ACTIVITIES; DRUG DEVELOPMENT; ENDOCANNABINOID; FATTY ALCOHOLS; FOOD INTAKE; IN-VIVO; LOW DENSITY LIPOPROTEINS; MOLECULAR SIMILARITY; OBESITY; OLIVE OIL; PHENOLIC COMPOUNDS; POLAR HEAD; RECEPTOR INTERACTION;

ALCOHOLS; BIOACTIVITY; ETHERS; NUTRITION; PHENOLS; UNSATURATED COMPOUNDS; VEGETABLE OILS;

LEAD COMPOUNDS;

3,4-DIHYDROXYPHENYLETHANOL; ANTIOBESITY AGENT; ANTIOXIDANT; CANNABINOID 1 RECEPTOR; DRUG DERIVATIVE; FATTY ALCOHOL; HYDROXYTYROSOL; LOW DENSITY LIPOPROTEIN; OLIVE OIL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHENETHYL ALCOHOL; PHENOL DERIVATIVE; VEGETABLE OIL;

ANIMAL; ARTICLE; CEREBELLUM; CHEMISTRY; DRUG EFFECT; EATING; LIPID PEROXIDATION; MALE; METABOLISM; RAT; WISTAR RAT;

ANIMALS; ANTI-OBESITY AGENTS; ANTIOXIDANTS; CEREBELLUM; EATING; FATTY ALCOHOLS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; PHENOLS; PHENYLETHYL ALCOHOL; PLANT OILS; PPAR ALPHA; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1;

RATTUS;

EID: 84856551419     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf203814r     Document Type: Article

References (35)

1. Glass, C. K.; Witztum, J. L. Atherosclerosis: the road ahead Cell 2001, 104, 503-516 (Pubitemid 32201946)
2. Steinberg, D. The LDL modification hypothesis of atherogenesis: an update J. Lipid Res. 2009, 50 (Suppl.) S376-S381
3. Visioli, F.; Bellomo, G.; Montedoro, G.; Galli, C. Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents Atherosclerosis 1995, 117, 25-32
4. Gordon, M. H.; Martins, F. P.; Almeida, M. Antioxidant activity of hydroxytyrosol acetate compared with that of other olive oil polyphenols J. Agric. Food Chem. 2001, 49, 2480-2485 (Pubitemid 32843278)
5. Mateos, R.; Domínguez, M. M.; Espartero, J. L.; Cert, A. Antioxidant effect of phenolic compounds, α-tocopherol, and other minor components in virgin olive oil J. Agric. Food Chem. 2003, 51, 7170-7175
6. Casas, E. M.; Covas, M. I.; Farre, M.; Fito, M.; Ortuño, J.; Weinbrenner, T.; Roset, P.; de la Torre, R. Hydroxytyrosol disposition in humans Clin. Chem. 2003, 49, 945-952 (Pubitemid 36623475)
7. Trujillo, M.; Mateos, R.; de Teran, L. C.; Espartero, J. L.; Cert, R.; Jover, M.; Alcudia, F.; Bautista, J.; Cert, A.; Parrado, J. Lipophilic hydroxytyrosyl esters. Antioxidant activity in lipid matrices and biological systems J. Agric. Food Chem. 2006, 54, 3779-3785 (Pubitemid 44030555)
8. Madrona, A.; Pereira-Caro, G.; Mateos, R.; Rodríguez, G.; Trujillo, M.; Fernández-Bolaños, J.; Espartero, J. L. Synthesis of hydroxytyrosyl alkyl ethers from olive oil waste waters Molecules 2009, 14, 1762-1772
9. Pereira-Caro, G.; Madrona, A.; Bravo, L.; Espartero, J. L.; Alcudia, F.; Cert, A.; Mateos, R. Antioxidant activity evaluation of alkyl hydroxytyrosyl ethers, a new class of hydroxytyrosol derivatives Food Chem. 2009, 115, 86-91
10. Pereira-Caro, G.; Sarri, B.; Madrona, A.; Espartero, J. L.; Goya, L.; Bravo, L.; Mateos, R. Alkyl hydroxytyrosyl ethers show protective effects against oxidative stress in HepG2 cells J. Agric. Food Chem. 2011, 59, 5964-5976
11. Pereira-Caro, G.; Bravo, L.; Madrona, A.; Espartero, J. L.; Mateos, R. Uptake and metabolism of new synthetic lipophilic derivatives, hydroxytyrosyl ethers, by Hhuman hepatoma HepG2 cells J. Agric. Food Chem. 2010, 58, 798-806
12. Pereira-Caro, G.; Mateos, R.; Saha, S; Madrona, A.; Espartero, J. L.; Bravo, L.; Kroon, P. A. Transepithelial transport and metabolism of new lipophilic ether derivatives of hydroxytyrosol by enterocyte-like Caco-2/TC7 cells J. Agric. Food Chem. 2010, 58, 11501-11509
13. Haslam, D. W.; James, W. P. Obesity Lancet 2005, 366, 1197-1209 (Pubitemid 41393598)
14. Calle, E. E.; Rodriguez, C.; Walker-Thurmond, K; Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N. Engl. J. Med. 2003, 348, 1625-1638 (Pubitemid 36459468)
15. Mackie, K. Cannabinoid receptors as therapeutic targets Annu. Rev. Pharmacol. 2006, 46, 101-122
16. Kota, B. P.; Huang, T. H.; Roufogalis, B. D. An overview on biological mechanisms of PPARs Pharmacol. Res. 2005, 51, 85-94 (Pubitemid 40040538)
17. O'Sullivan, S. Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors Br. J. Pharmacol. 2007, 152, 576-582 (Pubitemid 350034977)
18. Almeida, B.; Joglar, J.; Luque-Rojas, M. J.; Decara, J. M.; Bermúdez-Silva, F. J.; Macías-Gonzalesz, M.; Fitó, M.; Romero, M.; Farré, M.; Covas, M.; de Fonseca, F. R.; de la Torre, R. Synthesis of fatty acid amides of catechol metabolites that exhibit antiobesity properties ChemMedChem 2010, 5, 1781-1787
19. Lempiaien, H.; Molnar, H.; Gonzalez, M. M.; Perakyla, M.; Carlberg, C. Antagonist and inverse agonist-driven interactions of the vitamin D receptor and the constitutive androstane receptor with corepressor protein Mol. Endocrinol. 2005, 19, 2258-2272 (Pubitemid 41252821)
20. Gonzalez, M. M.; Samenfeld, P.; Perakyla, M.; Carlberg, C. Corepressor excess shifts the two-side chain vitamin D analog gemini from an agonist to an inverse agonist of the vitamin D receptor Mol. Endocrinol. 2003, 17, 2028-2038 (Pubitemid 37281795)
21. Alvarado, M.; Goya, P.; Macias-Gonzalez, M.; Pavon, F. J.; Serrano, A.; Jagerovic, N.; Elguero, J.; Gutierrez-Rodriguez, A.; García-Granda, S.; Suardiaz, M.; Rodríguez de Fonseca, F. Antiobesity designed multiple ligands: synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents Bioorg. Med. Chem. 2008, 18, 10098-10105
22. Gambacorta, A.; Tofani, D.; Bernini, R.; Migliorini, A. High-yielding preparation of a stable precursor of hydroxytyrosol by total synthesis and from the natural glycoside poleuropein J. Agric. Food Chem. 2007, 55, 3386-3391 (Pubitemid 46806552)
23. van Heerden, F. R.; van Zyl, J. J.; Rall, G. J. H.; Brandt, E. V.; Roux, D. G. Phase-transfer catalysis: a general method of methoxymethylation of the hydroxyl function Tetrahedron Lett. 1978, 19, 661-662
24. Harcken, C.; Brückner, R. Elucidation of the stereostructure of the annonaceous acetogenin (+)-montecristin through total synthesis New J. Chem. 2001, 25, 40-54 (Pubitemid 32164798)
25. Freedman, H. H.; Dubois, R. A. An improved Williamson ether synthesis using phase transfer catalysis Tetrahedron Lett. 1975, 16, 3251-3254
26. Rosenthal, A. F.; Vargas, L. A.; Dixon, J. F. Synthesis of long-chain ethers by phase-transfer. Improved preparation of d -mannitol 1,2,5,6-tetraoctadecyl ether Chem. Phys. Lipids 1977, 20, 205-209
27. Fitó, M.; Covas, M. I.; Raventós, R. M. L.; Vila, J.; de la Torre, C.; Marrugat, J. Aceite de oliva e inhibición de la oxidación de las lipoproteínas de baja densidad. Importancia de los compuestos fenólicos Med. Clin. (Barcelona) 2000, 115, 166-169
28. de Fonseca, F. R.; Navarro, M.; Gómez, R.; Escuredo, L.; Nava, F.; Fu, J.; Murillo-Rodríguez, E.; Giuffrida, A.; LoVerme, J.; Gaetani, S.; Kathuria, S.; Galk, C.; Piomelli, D. An anorexic lipid mediator regulated by feeding Nature 2001, 414, 209-212 (Pubitemid 33051235)
29. Fu, J.; Gaetani, S.; Oveisi, F.; LoVerme, J.; Serrano, A.; de Fonseca, F. R.; Rosengarth, A.; Lueke, H.; Giacomo, B. D.; Tarzia, G.; Piomelli, D. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α Nature 2003, 425, 90-93 (Pubitemid 37101723)
30. Griffin, G.; Wray, E. J.; Martin, B. R.; Abood, M. E. Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum Br. J. Pharmacol. 1999, 128, 684-688 (Pubitemid 29504760)
31. Rodríguez de Fonseca, F. Should we ever treat obesity? The case of Rimonabant Obes. Metab.-Milan 2008, 4, 192
32. Oveisi, F.; Gaetani, S.; Eng, K. T.; Piomelli, D. Oleoylethanolamide inhibits food intake in free-feeding rats after oral administration Pharmacol. Res. 2004, 49, 461-466 (Pubitemid 38283867)
33. Plaza-Zabala, A.; Berrendero, F.; Suarez, J.; Bermudez-Silva, F. J.; Fernandez-Espejo, E.; Serrano, A.; Pavon, F. J.; Parsons, L. H.; De Fonseca, F. R.; Maldonado, R.; Robledo, P. Effects of the endogenous PPAR-α agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice Synapse 2010, 64, 379-389
34. 1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats. Neuropharmacology 2008, 54, 226-234.
35. Rodríguez de Fonseca, F.; de la Torre, R.; Joglar, J. Unpublished observation.